Related Experiment Videos
Serotonergic agents and alcoholism treatment: a simulation
1University of Michigan, Department of Psychiatry, Addiction Research Center, Ann Arbor 48108, USA. sstolten@umich.edu
Alcoholism, Clinical and Experimental Research
|December 24, 2003
Summary
Genetic variants in the serotonin transporter gene (5-HTTLPR) may influence alcoholism treatment response. This study simulated how different genotypes affect serotonin and dopamine levels during treatment for alcohol use disorder.
Area of Science:
- Neuroscience
- Pharmacogenetics
- Computational Biology
Background:
- Alcoholism treatment response varies with onset age, potentially linked to serotonin transporter gene (5-HTTLPR) variants.
- Johnson's model proposes 5-HTTLPR influences serotonin (5-HT) and dopamine (DA) systems, affecting treatment outcomes for early- and late-onset alcoholism.
Purpose of the Study:
- To formalize and extend Johnson's model of alcoholism treatment response into a computational simulation.
- To investigate the influence of 5-HTTLPR genotype on neurochemical and behavioral responses during alcoholism treatment.
Main Methods:
- Developed a computer simulation using differential equations based on Johnson's model.
- Ran 100 simulations for 16 conditions, varying genotype, drinking status, diagnostic status, and drug treatment (ondansetron, SSRI).
Main Results:
- S/_ genotypes consistently showed higher extracellular 5-HT and postsynaptic DA firing rates than L/L, except for SSRI treatment.
- Alcohol consumption increased extracellular 5-HT and postsynaptic DA firing, with genotype-dependent effects under SSRI and ondansetron treatment.
Conclusions:
- 5-HTTLPR genotype may modulate the rewarding effects of alcohol during treatment.
- This genetic factor could influence alcohol craving pathways, suggesting a need for clinical investigation.